y polymerase chain reaction in children with Hodgkin disease: a Children's Cancer Group Lymphoma Biology Study. J Pediatr Hematol Oncol 23, 282-285. Simmons, A., Demmrich, Y., La Vista, A. & Smith, K. (1992). Replication of human herpesvirus 6 in epithelial cells in vitro. J Infect Dis 166, 202-205. Skinni<strong>de</strong>r, B. F., Elia, A. J., Gascoyne, R. D., Patterson, B., Trumper, L., Kapp, U. & Mak, T. W. (2002). Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99, 618-626. Snoeck, R. & De C<strong>le</strong>rcq, E. (2002). Ro<strong>le</strong> of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. Curr Opin Investig Drugs 3, 1561-1566. Sobue, R., Miyazaki, H., Okamoto, M., Hirano, M., Yoshikawa, T., Suga, S. & Asano, Y. (1991). Fulminant hepatitis in primary human herpesvirus-6 infection. N Engl J Med 324, 1290. Soldan, S. S., Berti, R., Sa<strong>le</strong>m, N., Secchiero, P., Flamand, L., Calabresi, P. A., Brennan, M. B., Maloni, H. W., McFarland, H. F., Lin, H. C., Patnaik, M. & Jacobson, S. (1997). Association of human herpes virus 6 (HHV-6) with multip<strong>le</strong> sc<strong>le</strong>rosis: increased IgM response to HHV-6 early antigen and <strong>de</strong>tection of serum HHV-6 DNA. Nat Med 3, 1394- 1397. Soldan, S. S., Leist, T. P., Juhng, K. N., McFarland, H. F. & Jacobson, S. (2000). Increased lymphoproliferative response to human herpesvirus <strong>type</strong> 6A variant in multip<strong>le</strong> sc<strong>le</strong>rosis patients. Ann Neurol 47, 306-313. Sorg, U. R., Morse, T. M., Patton, W. N., Hock, B. D., Angus, H. B., Robinson, B. A., Colls, B. M. & Hart, D. N. (1997). Hodgkin's cells express CD83, a <strong>de</strong>ndritic cell lineage associated antigen. Pathology 29, 294-299. Soul-Lawton, J., Seaber, E., On, N., Wootton, R., Rolan, P. & Posner, J. (1995). Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 39, 2759-2764. Stark, G. L., Wood, K. M., Jack, F., Angus, B., Proctor, S. J. & Taylor, P. R. (2002). Hodgkin's disease in the el<strong>de</strong>rly: a population-based study. Br J Haematol 119, 432-440. Stein, H., Marafioti, T., Foss, H. D., Laumen, H., Hummel, M., Anagnostopoulos, I., Wirth, T., Demel, G. & Falini, B. (2001). Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 97, 496-501. Sturtz, F. G., Cioffi, L., Wittmer, S., Sonk, M. J., Shafer, A., Li, Y., Leeper, N. J., Smith- Gbur, J., Shulok, J. & Platika, D. (1998). Tetracycline-regulatab<strong>le</strong> expression vectors tightly regulate in vitro gene expression of secreted proteins. Gene 221, 279-285. Suga, S., Yoshikawa, T., Asano, Y., Nakashima, T., Yazaki, T., Fukuda, M., Kojima, S., Matsuyama, T., Ono, Y. & Oshima, S. (1992). IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol Immunol 36, 495-506. Sullivan, J. R. & Shear, N. H. (2001). The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 137, 357-364. Sumiyoshi, Y., Kikuchi, M., Ohshima, K., Takeshita, M., Eizuru, Y. & Minamishima, Y. (1993). Analysis of human herpes virus-6 genomes in lymphoid malignancy in Japan. J Clin Pathol 46, 1137-1138. Sumiyoshi, Y., Kikuchi, M., Ohshima, K., Takeshita, M., Eizuru, Y. & Minamishima, Y. (1995). A case of human herpesvirus-6 lympha<strong>de</strong>nitis with infectious mononuc<strong>le</strong>osis-like 178
syndrome. Pathol Int 45, 947-951. Suzuki, Y., Inagi, R., Aono, T., Yamanishi, K. & Shiohara, T. (1998). Human herpesvirus 6 infection as a risk factor for the <strong>de</strong>velopment of severe drug-induced hypersensitivity syndrome. Arch Dermatol 134, 1108-1112. Takahashi, H., Hi<strong>de</strong>shima, K., Kawazoe, K., Tsuda, N., Fujita, S., Shibata, Y., Okabe, H. & Yamabe, S. (1995). Immunopheno<strong>type</strong>s of Reed-Sternberg cells and their variants: a study of 68 cases of Hodgkin's disease. Tohoku J Exp Med 177, 193-211. Takahashi, K., Sonoda, S., Higashi, K., Kondo, T., Takahashi, H., Takahashi, M. & Yamanishi, K. (1989). Predominant CD4 T-lymphocyte tropism of human herpesvirus 6related virus. J Virol 63, 3161-3163. Takemoto, M., Mori, Y., Ueda, K., Kondo, K. & Yamanishi, K. (2004). Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J Gen Virol 85, 869-879. Tamagawa-Mineoka, R., Katoh, N., Nara, T., Nishimura, Y., Yamamoto, S. & Kishimoto, S. (2007). DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6. Int J Dermatol 46, 654-655. Tanaka-Taya, K., Sashihara, J., Kurahashi, H., Amo, K., Miyagawa, H., Kondo, K., Okada, S. & Yamanishi, K. (2004). Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol 73, 465-473. Tejada-Simon, M. V., Zang, Y. C., Hong, J., Rivera, V. M. & Zhang, J. Z. (2003). Crossreactivity with myelin basic protein and human herpesvirus-6 in multip<strong>le</strong> sc<strong>le</strong>rosis. Ann Neurol 53, 189-197. Terrin, L., Dal Col, J., Rampazzo, E., Zancai, P., Pedrotti, M., Ammirabi<strong>le</strong>, G., Bergamin, S., Rizzo, S., Dolcetti, R. & De Rossi, A. (2008). Latent membrane protein 1 of Epstein- Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes. J Virol 82, 10175-10187. Theodore, W. H., Epstein, L., Gaillard, W. D., Shinnar, S., Wainwright, M. S. & Jacobson, S. (2008). Human herpes virus 6B: a possib<strong>le</strong> ro<strong>le</strong> in epi<strong>le</strong>psy? Epi<strong>le</strong>psia 49, 1828-1837. Thompson, J., Choudhury, S., Kashanchi, F., Doniger, J., Berneman, Z., Frenkel, N. & Rosenthal, L. J. (1994). A transforming fragment within the direct repeat region of human herpesvirus <strong>type</strong> 6 that transactivates HIV-1. Oncogene 9, 1167-1175. Tohyama, M., Hashimoto, K., Yasukawa, M., Kimura, H., Horikawa, T., Nakajima, K., Urano, Y., Matsumoto, K., Iijima, M. & Shear, N. H. (2007). Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157, 934-940. Tohyama, M., Yahata, Y., Yasukawa, M., Inagi, R., Urano, Y., Yamanishi, K. & Hashimoto, K. (1998). Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 134, 1113-1117. Torelli, G., Barozzi, P., Marasca, R., Cocconcelli, P., Merelli, E., Ceccherini-Nelli, L., Ferrari, S. & Luppi, M. (1995). Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuc<strong>le</strong>ar cells in vivo. J Med Virol 46, 178-188. Torelli, G., Marasca, R., Luppi, M., Sel<strong>le</strong>ri, L., Ferrari, S., Narni, F., Mariano, M. T., Fe<strong>de</strong>rico, M., Ceccherini-Nelli, L., Bendinelli, M. & et al. (1991). Human herpesvirus- 6 in human lymphomas: i<strong>de</strong>ntification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. Blood 77, 2251-2258. 179
- Page 1:
UNIVERSITE DE LIMOGES ECOLE DOCTORA
- Page 4 and 5:
Sommaire Liste des figures p.7 List
- Page 6 and 7:
VI.2. Nouvelles approches p.71 Trav
- Page 8 and 9:
Liste des tableaux Tableau 1 Caract
- Page 10 and 11:
IE immediate early Ig immunoglobuli
- Page 12 and 13:
Sous-famille Virus Alphaherpesvirin
- Page 14 and 15:
Environnement bibliographique Parti
- Page 16 and 17:
II.2. Génome Le génome d’HHV-6
- Page 18 and 19:
U2-U19 U27-U37 U38-U40 U41-U46 U48-
- Page 20 and 21:
sont détectés environ 3h après l
- Page 22 and 23:
IV.4. Encapsidation Les signaux sp
- Page 24 and 25:
V. Effets du virus sur la cellule h
- Page 26 and 27:
VII. Physiopathologie de l’infect
- Page 28 and 29:
présence d’ADN de l’HHV-6 dans
- Page 30 and 31:
IX. 2. Infection des immunodéprim
- Page 32 and 33:
détails ultérieurement. De façon
- Page 34 and 35:
a b Figure 6 : Effet cytopathogène
- Page 36 and 37:
XI.1. Analogues nucléosidiques L
- Page 38 and 39:
Acyclovir (Zovirax ®) Valacyclovir
- Page 40 and 41:
Partie 2 : Le syndrome d’hypersen
- Page 42 and 43:
jours, et pouvant atteindre 38 à 4
- Page 44 and 45:
Carbamazépine, phénytoïne, valpr
- Page 46 and 47:
III. Implication virale Une étroit
- Page 48 and 49:
sus-citées (figure 11). Des travau
- Page 50 and 51:
La reconnaissance du syndrome le pl
- Page 52 and 53:
A B Figure 12 : Coupe histologique
- Page 54 and 55:
lymphome nodulaire est surtout fré
- Page 56 and 57:
maladie indolente avec des récidiv
- Page 58 and 59:
Facteurs associés à un pronostic
- Page 60 and 61:
Les cellules HRS présentent un imm
- Page 62 and 63:
IV.3. Dérégulation de l’express
- Page 64 and 65:
Figure 15 : Reprogrammation génét
- Page 66 and 67:
Un gain génétique est également
- Page 68 and 69:
transgéniques exprimant LMP1 déve
- Page 70 and 71:
Références Méthode de détection
- Page 72 and 73:
supprimer l’expression de la prot
- Page 74 and 75:
Partie 1 : Etude du rôle de l’HH
- Page 76 and 77:
Drogue Charge virale Figure 17 : D
- Page 78 and 79:
Dilution du stock viral Volume de s
- Page 80 and 81: Acide valproïque Carbamazépine Ph
- Page 82 and 83: IV. Article 2 Amoxicillin-induced f
- Page 84 and 85: % viabilité cellulaire 140 120 100
- Page 86 and 87: VI. Etude d’une cohorte de patien
- Page 88 and 89: VII. Article 3 Drug Reaction with E
- Page 90 and 91: de monocytoses ou de lymphadénopat
- Page 92 and 93: Nombre de copie de EBNA1 (% contrô
- Page 94 and 95: injectées à des souris immunodép
- Page 96 and 97: Au sein du laboratoire de microbiol
- Page 98 and 99: égion V du gène des immunoglobuli
- Page 100 and 101: IV. Article 4 Involvement of human
- Page 102 and 103: I. Discussion des articles 4 et 5 L
- Page 104 and 105: Récepteur Cytoplasme Figure 24 : M
- Page 106 and 107: Conclusions - perspectives Ce trava
- Page 108 and 109: moindre importance. Il serait inté
- Page 110 and 111: perte relative du programme d’exp
- Page 112 and 113: d’orienter la recherche de déré
- Page 114 and 115: Alexander, F. E., Jarrett, R. F., L
- Page 116 and 117: D. V. & DiPaolo, J. A. (1994a). Hum
- Page 118 and 119: Lancet 2, 390. Dutton, A., Reynolds
- Page 120 and 121: herpesvirus 6 (HHV6) and human herp
- Page 122 and 123: in the IkappaBalpha gene in the mal
- Page 124 and 125: development in human germinal centr
- Page 126 and 127: (HHV-6) variant A from a parent to
- Page 128 and 129: Renne, C., Martin-Subero, J. I., Ei
- Page 132 and 133: Torlakovic, E., Tierens, A., Dang,
- Page 134 and 135: Young, L. S. & Murray, P. G. (2003)